Conclusion: Clonidine and dexmedetomidine may provide additional benefit in managing alcohol withdrawal by offering a different mechanism of action for targeting withdrawal symptoms.

After over a decade spent building Incyte up into a competitive commercial drugmaker, the company’s longtime CEO Hervé Hoppenot is making his exit and passing the baton to biopharma veteran ...

Clonidine and guanfacine can help reduce some of the side effects of stimulant therapy, especially sleeplessness and aggressive behavior.

There are 4 case reports suggesting clinical efficacy with dexmedetomidine in patients admitted for acute alcohol withdrawal uncontrolled by benzodiazepines. These case reports demonstrate control ...